Intra-Cellular Therapies to Present at the Cantor Fitzgerald Global Healthcare Conference
NEW YORK, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system ("CNS") disorders, today announced that Sharon Mates, Ph. …